JDPNX
Price
$17.09
Change
-$0.10 (-0.58%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

JDPNX vs VMVAX

Header iconJDPNX vs VMVAX Comparison
Open Charts JDPNX vs VMVAXBanner chart's image
Janus Henderson Mid Cap Value N
Price$17.09
Change-$0.10 (-0.58%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JDPNX vs VMVAX Comparison Chart
Loading...
VS
JDPNX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDPNX is a StrongBuy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. JDPNX (2.13B). VMVAX pays higher dividends than JDPNX: VMVAX (2.14) vs JDPNX (1.18). JDPNX was incepted earlier than VMVAX: JDPNX (12 years) vs VMVAX (13 years). JDPNX is a more actively managed with annual turnover of: 54.00 vs. VMVAX (22.00). VMVAX has a lower initial minimum investment than JDPNX: VMVAX (3000) vs JDPNX (1000000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. JDPNX (17.79). VMVAX return over 5 years is better than : 48.82 vs. JDPNX (17.80).
JDPNXVMVAXJDPNX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years13 years-
Gain YTD15.60214.946104%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets2.13B30.5B7%
Annual Yield % from dividends1.182.1455%
Returns for 1 year17.7925.3570%
Returns for 3 years3.8220.7118%
Returns for 5 years17.8048.8236%
Returns for 10 years-19.67100.88-20%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio